Teva sets out to delay generic competitor to Copaxone
October 31, 2016Sales and Marketing Copaxone, Teva, Teva Pharmaceutical, generics
Teva Pharmacetuical, the Israel-based pharmaceutical company, submitted a document to the FDA on 30 October; the document outlines the differences …
Astellas snatches up oncology firm Ganymed for $1.4 billion
October 31, 2016Research and Development, Sales and Marketing Astellas, Ganymed, IMAB362
Japanese pharma firm Astellas is set to bolster its oncology business with the acquisition of Ganymed Pharmaceuticals in a deal …
AstraZeneca’s head and neck cancer treatment clinical trials put on hold
October 31, 2016Sales and Marketing AstraZeneca, clinical hold, clinical trials, immunotherapy, phase III
AstraZeneca, the Cambridge-based British company, had recruitment for its final stage Phase III trials placed on partial hold. The drug …
Novartis elects new MD for UK plant
October 28, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment
Novartis has named Cynthia Chiaramitara as managing director of its plant in Grimsby, UK. She will take on the role …
Allergan in $200 million purchase of biopharmaceutical
October 28, 2016Medical Communications Allergan, Motus Therapeutics, Rythm Holding, Teva
Allergan will acquire Motus Therapeautics, a biopharmaceutical company that specialises in developing treatments for gastroparesis. It is another acquisition that …
Top ten stories in the pharmaceutical industry this week
October 28, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Halloween is creeping up, and its business as usual for the pharma industry; the week has been full of shockers, …
BMS unveils reorganisation plans & boosted profits
October 28, 2016Business Services, Medical Communications Bristol-Myers Squibb, Yervoy, opdivo
BMS has announced its intention to restructure its operations alongside $3 billion share buyback and quarterly results which exceeded expectations.The …
Male birth control injection has high efficacy but side-effects halt trials
October 28, 2016Medical Communications WHO, birth control, male contraceptive, pregnancies
The study, funded by the World Health Organization, found a jab was close to 96% effective in tests to ascertain …
J&J pays $70m over cancer allegations
October 28, 2016Medical Communications JJohnson & Johnson, ovarian cancer
Johnson & Johnson has been forced to pay out $70 million after it was alleged that years of using the …
Placebo discovery could change how clinical trials operate
October 28, 2016Medical Communications Northwestern Medicine, Rehabilitation Institute of Chicago, brain, fMRI, pain relief
Researchers from Northwestern Medicine and the Rehabilitation Institute of Chicago (RIC) have pinpointed, for the first time, exactly which region …
Adents and Microsoft pool resources to create new cloud platform
October 27, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adents, EU, France, Microsoft
Adents, a French software developer for unique production identification and ‘Track & Trace’ solutions, and Microsoft have developed, with an …
Sanofi forms new alliance to fight zika in Brazil
October 27, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Zika
Sanofi has teamed up with Brazilian research institute Fiocruz to accelerate development of a zika vaccine.This is another step in …
Teva team up with IBM to tackle two challenges facing the pharma industry
October 27, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, Teva Pharmaceutical, asthma, ibm
Teva Pharmaceuticals and IBM have announced a partnership that will use IBM Watson Health Cloud with the aim of finding …
Oxford Genetics gets further £1 million investment boost
October 27, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mercia Technologies, Oxford Genetics, synthetic biology
Warwickshire-based biotech Mercia Technologies has injected a further £1 million into synthetic biology- specialist Oxford Genetics, bringing their total investment …
AZ reveals compelling PhIII data for ovarian cancer treatment
October 26, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AstraZeneca, lynparza
AstraZeneca has revealed new results from a Phase III trial investigating the efficacy of its Lynparza drug as a monotherapy …
Price hiking: US pharma’s elephant in the room
October 26, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes
Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …
The November Issue of Pharmafocus is now live!
October 26, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, features, latest news, news
The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …
Nordic Nanovector to collaborate with Heidelberg Pharma to develop leukaemia treatment
October 26, 2016Research and Development Nordic Nanovector, WILEX, heidelberg pharma, leukaemia
Nordic Nanovector has announced that they have formed a partnership with WILEX subsidiary, Heidelberg Pharma. Heidelberg Pharma specialises in the …
NHS suppliers investigated over 1000% price hikes
October 26, 2016Research and Development, Sales and Marketing NHS, price hikes
The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs …
Backlash over testosterone replacement drugs builds with FDA warnings
October 26, 2016Research and Development FDA, FDA Warning, low t, prescription testosterone
The backlash against the over-prescription of ‘testosterone boosters’ continues in the US, with the FDA taking action to add clear …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
